Search

Search Constraints

You searched for: Author/Creator van de, Helgi

Search Results

1. A phase 2 multicentre study of siltuximab, an anti‐interleukin‐6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. (25th February 2013)